Nasdaq Closing Bell Ceremony (October 17, 2019)
CellPress : Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity | Eric Vivier
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
Interview "face aux dirigeants" de Mondher Mahjoubi au salon Actionaria
Webcast Replay (October 23th, 2018) : Expansion of oncology development collaboration with AstraZeneca
Access to the webcast: https://edge.media-server.com/m6/p/dic9yxpo Read the press release Transaction Fact Sheet Download the presentation